These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2483394)

  • 1. Cutaneous late phase responses--an allergic inflammatory response.
    Atkins PC
    Allergy Proc; 1989; 10(6):417-21. PubMed ID: 2483394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions.
    Piliponsky AM; Pickholtz D; Gleich GJ; Levi-Schaffer F
    J Allergy Clin Immunol; 2001 Jun; 107(6):993-1000. PubMed ID: 11398076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses.
    Van Loveren H; Kraeuter-Kops S; Askenase PW
    Eur J Immunol; 1984 Jan; 14(1):40-7. PubMed ID: 6198182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and pharmacologic modulation of the cutaneous late-phase reaction.
    Massey WA
    Ann Allergy; 1993 Dec; 71(6):578-84. PubMed ID: 7505536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of inflammatory events in skin sites with and without cutaneous late-phase reactions after prominent immediate IgE-mediated responses.
    Zweiman B; Moskovitz AR; von Allmen C
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):110-5. PubMed ID: 9449509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice.
    Askenase PW; Van Loveren H; Kraeuter-Kops S; Ron Y; Meade R; Theoharides TC; Nordlund JJ; Scovern H; Gerhson MD; Ptak W
    J Immunol; 1983 Dec; 131(6):2687-94. PubMed ID: 6605986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of terbutaline and bambuterol on immediate-type allergic skin responses and mediator release in human skin.
    Petersen LJ; Skov PS
    Inflamm Res; 2003 Sep; 52(9):372-7. PubMed ID: 14504664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late allergic reactions: the skin and the lung.
    Murphy S
    Cutis; 1984 Jun; 33(6):524-8, 531. PubMed ID: 6146497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of basophils in allergic disease.
    Knol EF; Mul FP; Lie WJ; Verhoeven AJ; Roos D
    Eur Respir J Suppl; 1996 Aug; 22():126s-131s. PubMed ID: 8871057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed-type hypersensitivity in mast cell-deficient mice: dependence on platelets for expression of contact sensitivity.
    Geba GP; Ptak W; Anderson GM; Paliwal V; Ratzlaff RE; Levin J; Askenase PW
    J Immunol; 1996 Jul; 157(2):557-65. PubMed ID: 8752902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities.
    Van Loveren H; Askenase PW
    J Immunol; 1984 Nov; 133(5):2397-401. PubMed ID: 6332849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells: makers and breakers of allergic inflammation.
    Hakim-Rad K; Metz M; Maurer M
    Curr Opin Allergy Clin Immunol; 2009 Oct; 9(5):427-30. PubMed ID: 19550301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4.
    Vennekens R; Olausson J; Meissner M; Bloch W; Mathar I; Philipp SE; Schmitz F; Weissgerber P; Nilius B; Flockerzi V; Freichel M
    Nat Immunol; 2007 Mar; 8(3):312-20. PubMed ID: 17293867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of mast cells to the late-phase of allergic asthma in rats.
    Liu S; Chihara K; Maeyama K
    Inflamm Res; 2005 May; 54(5):221-8. PubMed ID: 15953994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential patterns of inflammatory events during developing and expressed skin late-phase reactions.
    Zweiman B; Haralabatos IC; Pham NC; David M; von Allmen C
    J Allergy Clin Immunol; 2000 Apr; 105(4):776-81. PubMed ID: 10756229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of human cutaneous mast cells to anaphylactic and nonimmunological stimuli.
    Brzezińska-Błaszczyk E; Zalewska A
    Arch Immunol Ther Exp (Warsz); 1997; 45(1):55-9. PubMed ID: 9090441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does non-immunologic mast cell mediator release/activation elicit a late cutaneous response?
    Dolovich J; Denberg J; Kwee YN; Belda T; Blajchman J; Hargreave FE
    Ann Allergy; 1983 Apr; 50(4):241-4. PubMed ID: 6838021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cells in cutaneous inflammatory disorders.
    Soter NA
    J Invest Dermatol; 1983 Jun; 80 Suppl():22s-25s. PubMed ID: 6854053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
    Tam SW; Demissie S; Thomas D; Daëron M
    Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory responses to mast cell granules.
    Kaliner M; Lemanske R
    Fed Proc; 1984 Oct; 43(13):2846-51. PubMed ID: 6479357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.